Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESTORE: A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy

NCT02586623 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT02586623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESTORE: A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Lead sponsor
H. Lundbeck A/S
Phase
Phase 4
Overall status
Completed
Start date
February 11, 2016
Completion date
September 9, 2022
Enrollment
453 (actual)
Sites
168

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic neurogenic orthostatic hypotension